Clinical Trial: Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 Study

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07808918) titled 'Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 Study' on Sept. 03.

Brief Summary: This is a Phase 1, single-center, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of HRS-1597 tablets following single-dose administration in healthy participants and multiple-dose administration in obese participants, as well as the effect of food on the pharmacokinetics of HRS-1597 tablets.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Obese and Metabolic Disorders

Intervention: DRUG: HRS-1597

Specified dose on spe...